sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 22/12/2011
PIL Nozinan injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 22/04/2010 and displayed until 22/12/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 23/03/2009 and displayed until 22/04/2010
Reasons for adding or updating:
  • Change to date of revision
Updated on 15/09/2008 and displayed until 23/03/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 28/06/2006 and displayed until 15/09/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   levomepromazine hydrochloride